Key points are not available for this paper at this time.
The biocatalytic oxidative deamination of β-amino alcohols holds significant practical potential in kinetic resolution and/or deracemization process to access (R)-β-amino alcohols. This study exemplifies a notable instance of acquisition and utilization of this valuable oxidative deamination activity. Initially, the mutation N261M (M0) was identified to endow a native valine dehydrogenase with oxidative deamination activity toward a few (S)-β-amino alcohols. Subsequently, a phylogenetic analysis-guided, double-code saturation mutagenesis strategy was proposed to engineer M0's side-chain binding site. This strategy facilitated the substrate-specific evolution of M0, resulting in the creation of a panel of mutants (M1–M4) with noteworthy oxidative deamination activity toward structurally diverse (S)-β-amino alcohols. Using these engineered amine dehydrogenases, termed as β-amino alcohol dehydrogenases (β-AADHs), the complete kinetic resolution and even deracemization of a range of β-amino alcohols have been achieved. This work reports distinct biocatalysts and a synthetic strategy for the synthesis of enantiopure (R)-β-amino alcohols and offers an innovative approach for substrate-specificity engineering of enzymes.
Building similarity graph...
Analyzing shared references across papers
Loading...
Xinjian Yin
Wenzhong Gong
Yujing Zeng
ACS Catalysis
Delft University of Technology
Sun Yat-sen University
Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)
Building similarity graph...
Analyzing shared references across papers
Loading...
Yin et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d73cf852964041bdf306e3 — DOI: https://doi.org/10.1021/acscatal.3c04995
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: